Salvador Namur

Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: An open-label, randomized, two-period crossover comparison in healthy mexican volunteers

Juan Francisco Galán-Herrera, Jorge Luis Poo, Oscar Rosales-Sanchez et al. · Clinical Therapeutics · 2009 · 18 citations

Healthy Mexican Volunteers, Oral Formulations, Pharmacology +5

Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: A randomized, open-label, single-dose, two-period crossover comparison in healthy mexican adult volunteers

Juan Francisco Galán-Herrera, Jorge Luis Poo, Jose Alfonso Maya-Barrios et al. · Clinical Therapeutics · 2008 · 15 citations

Two-period Crossover Comparison, Pharmacological Study, Pharmacology +6

Bioavailability of two oral formulations of azithromycin 500 mg: A randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects

Alfredo Piñeyro-López, Everardo Piñeyro‐Garza, Oscar Torres-Alanís et al. · Clinical Therapeutics · 2005 · 15 citations

Therapeutic Drug Monitoring, Two-period Crossover Comparison, Oral Formulations +6

Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): Single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects

José Antonio Palma‐Aguirre, Jorge Villalpando-Hernández, Germán Novoa-Heckel et al. · Clinical Therapeutics · 2009 · 12 citations

Naproxen Sodium/paracetamol, Medicine, Two-period Crossover Comparisons +5

Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: Two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects

José Antonio Palma‐Aguirre, Jose Antonio Absalón-Reyes, Germán Novoa-Heckel et al. · Clinical Therapeutics · 2007 · 10 citations

Oral Tablet Formulations, Acyclovir 400, Pharmacological Study +5